
|Articles|February 8, 2020
Glaucoma 360 shines spotlight on innovation
Author(s)Sheryl Stevenson, Alex Delaney-Gesing
Advertisement
Glaucoma 360 co-founders and co-chairs Adrienne Graves, PhD, and Andrew Iwach, MD, sit down with Ophthalmology Times' Sheryl Stevenson to discuss a few of the highlights for this year’s meeting in San Francisco.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ocular Therapeutix randomizes first patient in HELIOS-3
2
AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives
3
AAO 2025 Takeaways: How imaging and remote monitoring are transforming retinal care
4
AGC Biologics to manufacture AAVantgarde’s dual-vector gene therapies, AVB-039 and AAVB-081
5


















































.png)


